(Q44434272)

2 December 2017

title

Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists (English)

1 reference

2 December 2017

4

Akinori Akaike

1 reference

2 December 2017

3

Shun Shimohama

1 reference

2 December 2017

Yoshihisa Kitamura

1

1 reference

2 December 2017

Takashi Taniguchi

series ordinal

2

1 reference

2 December 2017

Yasuyuki Nomura

series ordinal

5

1 reference

2 December 2017

publication date

1 July 2003

1 reference

2 December 2017

published in

Neurochemical Research

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

7

1 reference

2 December 2017

page(s)

1035-1040

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1023207222944

2 December 2017

exact match

0 references

cites work

Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

1 reference

12 December 2020

Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole

1 reference

12 December 2020

Antioxidant properties of bromocriptine, a dopamine agonist.

1 reference

12 December 2020

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

1 reference

12 December 2020

History of levodopa and dopamine agonists in Parkinson's disease treatment.

1 reference

12 December 2020

Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures

1 reference

12 December 2020

Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice

1 reference

12 December 2020

The parkinsonian models: invertebrates to mammals

1 reference

12 December 2020

Mitochondria and apoptosis

1 reference

12 December 2020

Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole

1 reference

12 December 2020

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

1 reference

12 December 2020

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity

1 reference

12 December 2020

Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons

1 reference

12 December 2020

Bcl-2 promotes regeneration of severed axons in mammalian CNS

1 reference

12 December 2020

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

1 reference

12 December 2020

Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.

1 reference

12 December 2020

Levodopa neurotoxicity: experimental studies versus clinical relevance

1 reference

12 December 2020

Pre-clinical studies of pramipexole: clinical relevance

1 reference

12 December 2020

Parkinson's disease: prospects for improved drug therapy

1 reference

12 December 2020

Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons.

1 reference

12 December 2020

Experimental models of Parkinson's disease

1 reference

12 December 2020

Neuroprotective effects of D3 dopamine receptor agonists

1 reference

12 December 2020

An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology

1 reference

12 December 2020

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

12 December 2020

Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster

1 reference

12 December 2020

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

1 reference

12 December 2020

Dopamine receptor functions: lessons from knockout mice [corrected].

1 reference

12 December 2020

Antioxidant and pro-oxidant capacity of catecholamines and related compounds. Effects of hydrogen peroxide on glutathione and sphingomyelinase activity in pheochromocytoma PC12 cells: potential relevance to age-related diseases

1 reference

12 December 2020

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

1 reference

12 December 2020

PTX-sensitive regulation of neurite outgrowth by the dopamine D3 receptor

1 reference

12 December 2020

Engineered modeling and the secrets of Parkinson's disease

1 reference

12 December 2020

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

1 reference

12 December 2020

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

1 reference

12 December 2020

Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.

1 reference

12 December 2020

Scavenging effects of dopamine agonists on nitric oxide radicals.

1 reference

12 December 2020

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

1 reference

12 December 2020

bcl-2 protein is increased in the brain from parkinsonian patients

1 reference

12 December 2020

The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.

1 reference

12 December 2020

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

1 reference

12 December 2020

Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist

1 reference

12 December 2020

Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.

1 reference

12 December 2020

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023207222944

1 reference

Dimensions Publication ID

2 December 2017

1032504561

0 references

1 reference